Growth Metrics

Cerus (CERS) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Cerus 549.42 Mn 469.73 Mn 27.89 Mn 929.27%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 929.27%
Dec 31, 2025 81.09%
Sep 30, 2025 -152.09%
Jun 30, 2025 84.68%
Mar 31, 2025 -182.23%
Dec 31, 2024 -188.68%
Sep 30, 2024 1,851.64%
Jun 30, 2024 -405.15%
Mar 31, 2024 187.85%
Dec 31, 2023 11.28%
Sep 30, 2023 86.69%
Jun 30, 2023 142.54%
Mar 31, 2023 -119.09%
Dec 31, 2022 118.32%
Sep 30, 2022 -109.51%
Jun 30, 2022 -155.54%
Mar 31, 2022 -59.70%
Dec 31, 2021 -629.99%
Sep 30, 2021 503.88%
Jun 30, 2021 717.99%
Mar 31, 2021 142.63%
Dec 31, 2020 -19.14%
Sep 30, 2020 -153.65%
Jun 30, 2020 63.99%
Mar 31, 2020 -480.62%
Dec 31, 2019 30.08%
Sep 30, 2019 1,792.08%
Jun 30, 2019 35.46%
Mar 31, 2019 129.47%
Dec 31, 2018 256.84%
Sep 30, 2018 104.30%
Jun 30, 2018 -158.71%
Mar 31, 2018 -888.42%
Dec 31, 2017 -124.65%
Sep 30, 2017 -198.21%
Jun 30, 2017 291.89%
Mar 31, 2017 112.59%
Dec 31, 2016 -18.75%
Sep 30, 2016 -52.58%
Jun 30, 2016 -134.58%
Mar 31, 2016 31.26%
Dec 31, 2015 728.32%
Sep 30, 2015 644.62%
Jun 30, 2015 641.10%
Mar 31, 2015 -2,285.74%
Dec 31, 2014 -963.68%
Sep 30, 2014 83.47%
Jun 30, 2014 1,523.35%
Mar 31, 2014 11,642.31%
Dec 31, 2013 2,928.57%
Sep 30, 2013 -83,965.71%
Jun 30, 2013 -656.67%
Mar 31, 2013 -113.27%
Dec 31, 2012 -94.87%
Sep 30, 2012 -132.11%
Jun 30, 2012 66.67%
Mar 31, 2012 20.25%
Dec 31, 2011 -1.09%
Sep 30, 2011 122.95%